MetaCap

Emmis Acquisition (EMIS) vs SIGA Technologies (SIGA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Emmis Acquisition (EMIS) has outperformed SIGA Technologies (SIGA) over the past year, gaining 4.4% versus a loss of 58.9%. SIGA Technologies is the larger company by market cap ($172.5 million vs $163.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EMIS+4.39%SIGA-58.90%
+23%-20%-63%
Nov 21, 20251 yearNov 20, 2026
EMIS+4.60%SIGA-71.56%
+8%-33%-75%
Oct 20, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EMIS versus SIGA key metrics
MetricEMISSIGA
Share price$10.36$2.40
Market cap$163.36M$172.45M
1-day change+0.15%-9.43%
YTD return+4.07%-60.72%
1-year return+4.39%-58.90%
5-year return—-71.90%
P/E ratio (TTM)—240.00
Forward P/E—5.45
EPS (TTM)—$0.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$94.57M
Revenue growth (YoY)—-31.82%
Net income (latest FY)—$23.28M
Gross margin—68.59%
Operating margin—25.06%
Net margin—24.61%
52-week high$10.38$7.11
52-week low$9.92$2.30
Distance from 52-week high-0.24%-66.24%
Analyst consensus—strong_buy
Avg. price target upside—+35.42%
Average volume16.19K617.60K
Shares outstanding11.94M71.86M
Employees—49
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • EMIS has outperformed SIGA by 63.3 percentage points over the past year.

About Emmis Acquisition

EMIS stock →

Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Health Care · Biotechnology: Pharmaceutical Preparations

About SIGA Technologies

SIGA stock →

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.

Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees

EMIS vs SIGA FAQ

Which is bigger, Emmis Acquisition or SIGA Technologies?

SIGA Technologies (SIGA) is larger, with a market capitalization of $172.45M compared with $163.36M for Emmis Acquisition (EMIS).

Which stock has performed better over the past year, EMIS or SIGA?

EMIS returned +4.39% over the past 12 months, compared with -58.90% for SIGA (price return, excluding dividends). Past performance does not predict future results.

Are Emmis Acquisition and SIGA Technologies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons